We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Actavis, Forest Labs Give Up 4 Generics In FTC Settlement

Law360, Los Angeles (June 30, 2014, 7:28 PM EDT) -- Pharmaceutical companies Actavis PLC and Forest Laboratories Inc. will sell or give up their rights to four generic drugs to settle the Federal Trade Commission's allegations that Actavis' $25 billion purchase...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.